What is Medpace?
Medpace is a clinical contract research organization company serving enterprise, public-sector, commercial, consumer, or regulated-market customers.
- Category
- Clinical contract research organization
- Headquarters
- Cincinnati, OH
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; Nasdaq: MEDP
What is Medpace?
Medpace is a clinical contract research organization company headquartered in Cincinnati, OH. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
Medpace is a clinical contract research organization company headquartered in Cincinnati, OH. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, Medpace should be mapped as a scaled public-company account rather than an early-stage company. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does Medpace offer?
Medpace's profile centers on Clinical trials, Regulatory support, Medical monitoring, Data management.
- Clinical trials· Clinical contract research organization
- Regulatory support· Clinical contract research organization
- Medical monitoring· Clinical contract research organization
- Data management· Clinical contract research organization
- Biometrics· Clinical contract research organization
- Therapeutic expertise· Clinical contract research organization
How does Medpace make money?
Medpace makes money through commercial activity tied to clinical contract research organization.
Medpace monetizes through the model common to clinical contract research organization: product sales, recurring services, subscriptions, contracts, distribution, transaction volume, underwriting, regulated utility revenue, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, uptime, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads Medpace?
Medpace's named executives should be verified on the official leadership or investor-relations page before outreach.
- Medpace executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Medpace finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- Medpace operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact Medpace's leadership?
Medpace should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.medpace.comHow is Medpace funded?
Medpace's current status is Public company; Nasdaq: MEDP.
Medpace's capital profile is best understood through its current public-company status: Public company; Nasdaq: MEDP. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capex plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did Medpace get here?
Medpace's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingMedpace is foundedThe company begins building in clinical contract research organization.
- Scale-upCommercial footprint expandsMedpace broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; Nasdaq: MEDPPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are Medpace's competitors?
Medpace competes with larger incumbents and focused specialists in clinical contract research organization.
- Thermo Fisher ScientificLife sciences tools, diagnostics, and services incumbent.
- DanaherLife sciences and diagnostics platform company.
- MedtronicGlobal medical technology competitor.
- PfizerLarge pharmaceutical company with global commercial reach.
- IQVIAHealthcare data and clinical research platform competitor.
Medpace — frequently asked questions
